Shandong Science ›› 2024, Vol. 37 ›› Issue (5): 1-9.doi: 10.3976/j.issn.1002-4026.20230175

• Traditional Chinese Medicine and Natural Active Products •     Next Articles

To explore the pharmacodynamic substance basis of Cervi Cornus Colla based on cell membrane chromatography

SUN Tiefeng1(), ZHAO Yu2, WANG Ping1,*(), DING Xianglong3, DING Lijun4, WANG Jinguo4   

  1. 1. Shandong Academic of Chinese Medicine, Jinan 250014,China
    2. Shandong University of Traditional Chinese Medicine,Jinan 250355,China
    3. Huangdao District Second Hospital of Traditional Chinese Medicine,Qingdao 266400,China
    4. Rizhao Traditional Chinese Medicine Hospital,Rizhao 276800,China
  • Received:2023-12-12 Published:2024-10-20 Online:2024-09-29
  • Contact: WANG Ping E-mail:suntiefenglove@163.com;wangpingjinan@163.com

Abstract:

Cell membrane chromatography/ultrahigh-phase liquid chromatography-mass spectrometry (CMC/UPLC-MS) was used to screen the active ingredients, i.e., peptides, in the traditional Chinese medicine tablet Cervi cornus Colla, and the obtained spectra were analyzed using Maxquant software, Perseus software, and Uniprot database. Structures of these peptides were identified using Protein Data Bank, and their molecular properties such as their biological activity, adverse reactions, relative molecular mass, isoelectric point, and stability index were predicted using a bioinformatics platform. With an activity probability of 0.09, the peptides were identified as nontoxic, nonhemolytic, sensitizing, and highly hydrophilic, with a relative molecular mass of 1 541.68, a peptide chain length of 14, an isoelectric point of 3.92, and an instability index of 34.39.This method provides a feasible research approach for rapidly screening and identifying active ingredients(e.g., peptides and proteins) that exhibit pharmacological effects.

Key words: Cervi Cornus Colla, cell membrane chromatography, bone marrow mesenchymal stem cells, interleukin-1β

CLC Number: 

  • R284

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0